As of 2026-04-05, the EV/EBITDA ratio of Hutchison China MediTech Ltd (HCM.L) is -26.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HCM.L's latest enterprise value is 1,733.96 mil GBP. HCM.L's TTM EBITDA according to its financial statements is -64.60 mil GBP. Dividing these 2 quantities gives us the above HCM.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.1x - 13.7x | 9.8x |
| Forward P/E multiples | 7.2x - 12.7x | 8.6x |
| Fair Price | (24.67) - (56.02) | (36.30) |
| Upside | -111.3% - -125.6% | -116.6% |
| Date | EV/EBITDA |
| 2026-04-02 | -36.30 |
| 2026-04-01 | -35.78 |
| 2026-03-31 | -34.91 |
| 2026-03-30 | -34.90 |
| 2026-03-27 | -31.60 |
| 2026-03-26 | -31.85 |
| 2026-03-25 | -33.16 |
| 2026-03-24 | -32.64 |
| 2026-03-23 | -32.99 |
| 2026-03-20 | -32.47 |
| 2026-03-19 | -32.64 |
| 2026-03-18 | -34.74 |
| 2026-03-17 | -34.56 |
| 2026-03-16 | -33.69 |
| 2026-03-13 | -33.87 |
| 2026-03-12 | -33.69 |
| 2026-03-11 | -35.26 |
| 2026-03-10 | -34.56 |
| 2026-03-09 | -34.21 |
| 2026-03-06 | -34.57 |
| 2026-03-05 | -32.46 |
| 2026-03-04 | -33.16 |
| 2026-03-03 | -32.68 |
| 2026-03-02 | -32.99 |
| 2026-02-27 | -34.74 |
| 2026-02-26 | -35.61 |
| 2026-02-25 | -35.61 |
| 2026-02-24 | -33.86 |
| 2026-02-23 | -35.96 |
| 2026-02-20 | -35.62 |
| 2026-02-19 | -35.61 |
| 2026-02-18 | -35.61 |
| 2026-02-17 | -34.56 |
| 2026-02-16 | -34.30 |
| 2026-02-13 | -34.74 |
| 2026-02-12 | -34.56 |
| 2026-02-11 | -35.43 |
| 2026-02-10 | -35.44 |
| 2026-02-09 | -34.21 |
| 2026-02-06 | -33.33 |
| 2026-02-05 | -35.26 |
| 2026-02-04 | -35.43 |
| 2026-02-03 | -35.09 |
| 2026-02-02 | -34.91 |
| 2026-01-30 | -35.62 |
| 2026-01-29 | -35.43 |
| 2026-01-28 | -35.61 |
| 2026-01-27 | -35.79 |
| 2026-01-26 | -36.75 |
| 2026-01-23 | -36.49 |